Skip to content

To study effect of Nayanasukha Varti Anjana and Antioxidant Therapy in Kaphaj Kacha- Senile Immature Cortical Cataract.

An Assessment of Effectiveness of Nayanasukha Varti Anjana with Antioxidant Therapy in Kaphaja Kacha (Senile Immature Cortical Cataract)- A Randomized Controlled Clinical Trial. - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/10/096410
Enrollment
60
Registered
2025-10-23
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H258- Other age-related cataract

Interventions

None listed

Sponsors

Dr. Neha Anant Bhatavadekar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients having symptoms of Senile Immature Cortical Cataract (Kaphaja Kacha) such as Cloudy vision (Tanuchailavrottopamam),Lustreless Vision (Nishprabh Induarkapradip), Gradual loss of vision (Drushti Hiyate Kramat), Glare. Uniocular Polyopia/Diplopia. Visual acuity between 6/9-6/36 by Snellen’s chart

Exclusion criteria

Exclusion criteria: Patients with Mature cataract and Hyper mature cataract. Visual acuity - less than 6/36 by Snellen’s chart. Patients with congenital and developmental, traumatic, complicated or metabolic cataract. Patients having any other Posterior Segment Disease such as ARMD, NPDR. Patients who are a K/C/O Uncontrolled DM/HTN/TB/IHD. Patients having any other Serious Systemic Disease, Glaucoma. Patients having symptoms of Timir, Vataj Kacha, Pittaj Kacha, All types of Linganash.

Design outcomes

Primary

MeasureTime frame
To study the effect of Nayanasukha Varti Anjana on symptoms of Kaphaja Kacha (Senile Immature Cortical Cataract) such as Tanuchailavrottopamam (Cloudy Vision), Nishprabh Induarkapradip (Lustreless Vision), Glare, Polyopia/Diplopia.Timepoint: Follow Up on 0th 15th 30th 45th 60th & 90th day with assessment

Secondary

MeasureTime frame
1.To study the effect seen in Visual Acuity. 2.To evaluate changes in Cataract Gradation, Graded as per Lens Opacification Criteria System (LOCS) III and Simplified Cataract Grading System based on Quadrant Occupied (COR). 3.To study effects seen in Contrast Sensitivity Test.Timepoint: Follow Up on 15th 30th 45th 60th & 90th day with assessment

Countries

India

Contacts

Public ContactDr Sunita Vijay Magar

Dr. G. D.Pol Foundation, YMT Ayurvedic Medical College.

sunitamagar66@gmail.com9987335024

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026